Glaxo Wellcome earmarks more for research

Pharmaceutical giant Glaxo Wellcome spent Pounds 1.15 billion on research and development in 1997, according to its annual report. The firm, which notched up global sales worth Pounds 8 billion, says it expects to spend Pounds 1.2 billion on R&D next year. It says that for the pharmaceutical industry worldwide, sales in 1997 were up 9 per cent to Pounds 166 billion.The North American market saw the greatest increase from 9 per cent growth in 1996 to 15 per cent in 1997, generating Pounds 61 billion of sales.

The United States accounts for 35 per cent of the global market. Europe has experienced a decline in growth from 9 per cent to 6 per cent. Growth in Latin America has increased from 7 per cent to 11 per cent, while in Asia Pacific growth has slowed from 13 per cent to 9 per cent.

Already registered?

Sign in now if you are already registered or a current subscriber. Or subscribe for unrestricted access to our digital editions and iPad and iPhone app.

Register to continue  

You've enjoyed reading five THE articles this month. Register now to get five more, or subscribe for unrestricted access.

Most Commented

  • Elly Walton illustration (16 July 2015)

Whether in jest or not, sexist language shows an insensitivity to gender issues at odds with academic values, argues Dorothy Bishop

  • Two men looking surprised in an office

Report says projects fail when scholars obsessed with “shiny things” ignore business needs

  • Tony Little, Eton College headmaster, 2007

Tony Little points to ‘increasing gap’ between teaching standards at sixth form and university

  • AC Grayling, writer and academic

A. C. Grayling’s ‘Oxbridge-style’ private college strikes agreement with post-92 institution